Vulpes Investment Management led the round, with the Additio Investment Group, Oxford Sciences Innovation PLC, Parkwalk Advisors, Perivoli Innovations, Oxford Investment Consultants, the University of Oxford and private individuals following on.
The Oxford University spin-out has previously won funding from the European Union’s Horizon 2020 SME instrument and the UK’s grant programme, Innovate UK.
Their OxiFlow micro stent was developed using ‘origami engineering’, which enabled its structure to be reduced and subsequently enlarged.
OxiFlow can be inserted into the brain blood vessels via minimally invasive groin access. It lies across the base of the aneurysm and causes it to shrink and heal. This ‘flow-diverter’ can be placed more accurately and safely than existing treatments, reducing the risk of complications and having to use multiple devices.
Check the project in the EIC datahub